Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM6Y0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,648
Award facts
- Contract value 100% obligated
- $15,647.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,647.60 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of HEPLISAV-B 20 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. HEPLISAV-B is a recombinant hepatitis B vaccine indicated for immunization of adults aged 18 and older, and this procurement supports the military's medical supply requirements through DLA's comprehensive pharmaceutical distribution network.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, secured this award through open competition with no set-aside designation. The company maintains an extensive portfolio of federal contracts with the Defense Logistics Agency, supplying pharmaceutical products and medical supplies to support military healthcare systems worldwide. This delivery order exemplifies AmerisourceBergen's role in fulfilling the Defense Health Agency's vaccine and immunization needs, consistent with the company's broader mandate to provide brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains for military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FM6Y0?
SPE2DR26FM6Y0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FM6Y0 worth?
The government has obligated $15,648 on SPE2DR26FM6Y0.
Is contract SPE2DR26FM6Y0 an order under another contract?
Yes. SPE2DR26FM6Y0 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM6Y0 competed?
The extent of competition for SPE2DR26FM6Y0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award